Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies

RH. Kobayashi, S. Gupta, I. Melamed, JF. Mandujano, AL. Kobayashi, B. Ritchie, B. Geng, TP. Atkinson, S. Rehman, E. Turpel-Kantor, J. Litzman

. 2022 ; 13 (-) : 1110388. [pub] 20221220

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu tisková chyba

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003344

[This corrects the article DOI: 10.3389/fimmu.2019.00040.].

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003344
003      
CZ-PrNML
005      
20230421095952.0
007      
ta
008      
230413s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2022.1110388 $2 doi
035    __
$a (PubMed)36605207
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kobayashi, Roger H $u UCLA School of Medicine, Los Angeles, CA, United States
245    10
$a Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies / $c RH. Kobayashi, S. Gupta, I. Melamed, JF. Mandujano, AL. Kobayashi, B. Ritchie, B. Geng, TP. Atkinson, S. Rehman, E. Turpel-Kantor, J. Litzman
520    9_
$a [This corrects the article DOI: 10.3389/fimmu.2019.00040.].
590    __
$a NEINDEXOVÁNO
655    _2
$a tisková chyba $7 D016425
700    1_
$a Gupta, Sudhir $u Division of Basic and Clinical Immunology, University of California, Irvine, Irvine, CA, United States
700    1_
$a Melamed, Isaac $u IMMUNOe Research Center, Centennial, CO, United States
700    1_
$a Mandujano, J Fernando $u Pediatric Pulmonary Associates of North Texas, Frisco, TX, United States
700    1_
$a Kobayashi, Ai Lan $u Midlands Pediatrics, Papillion, NE, United States
700    1_
$a Ritchie, Bruce $u Divisionof Hematology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada
700    1_
$a Geng, Bob $u Divisions of Adult and Pediatric Allergy and Immunology, University of California, San Diego, La Jolla, CA, United States
700    1_
$a Atkinson, Thomas Prescott $u Department of Pediatric Allergy, Asthma and Immunology, University of Alabama, Birmingham, AL, United States
700    1_
$a Rehman, Syed $u Allergy and Asthma Center Inc., Toledo, OH, United States
700    1_
$a Turpel-Kantor, Eva $u Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria
700    1_
$a Litzman, Jiří $u Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 13, č. - (2022), s. 1110388
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36605207 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20230421095944 $b ABA008
999    __
$a ok $b bmc $g 1922875 $s 1189551
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 13 $c - $d 1110388 $e 20221220 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20230413

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace